molecularly targeted therapy

0:03:40

Molecularly Targeted Therapies in Oncology: Episode 1

0:12:45

Understanding Molecularly Targeted Therapy for Metastatic Melanoma - Who Can Get It and When?

0:03:49

Molecularly Targeted Therapies in Oncology: Episode 4

0:04:45

Taking Hope from Molecularly Targeted Therapy

0:02:36

New combination therapies and molecularly targeted therapies

0:05:11

Camden Green: Fighting Childhood Cancer with Molecularly Targeted Therapy

0:03:13

Molecularly Targeted Therapies in Oncology: Episode 3

0:03:09

Molecularly Targeted Therapies in Oncology: Episode 2

0:12:20

Cost of & Access to Molecularly Targeted Therapies as Barriers to Optimal Care

0:45:10

Molecularly targeted therapies for cancer Part 1

0:34:11

Computational Reasoning for the N-of-1 Use of Molecularly Targeted Cancer Therapies

0:33:16

Introduction to NETs, Jennifer Chan MD, MPH, Dana-Farber

1:43:16

Molecularly Targeted Therapies Panel at FACTOR 2023

1:38:56

Taking Aim at GI Cancers With Personalized HER2 and Other Molecularly Targeted Therapies

0:31:20

A history of cancer immunotherapy - A/Prof Tri Phan

0:45:54

Molecular Classification of Endometrial Cancer and Targeted Therapy Considerations

0:01:31

MiST: molecularly targeted therapy for malignant pleural mesothelioma

0:42:23

Molecularly targeted therapies for cancer Part 2

1:30:46

Precision Treatment Planning With Molecularly Targeted Therapies in HER2+ GI Cancers

0:09:24

2018 NAM Annual Meeting - Overcoming Resistance to Molecularly Targeted Cancer Therapy

0:35:24

New Molecularly Guided Therapies in Advanced/Metastatic Cholangiocarcinoma: What You Need to Know

0:53:15

Kimberly Kelly - Development of molecularly targeted imaging agents and identification of novel targ

0:44:56

Advanced NSCLC: Refining Clinical Pathways in the Rapidly Evolving Therapeutic Landscape

0:00:58

Dr. Sullivan on Targeted Therapy for BRAF-Mutant Melanoma